Free shipping on all orders over $ 500

 About 8 results found for searched term "Tenofovir" (0.209 seconds)

Cat.No.  Name Target
M4958 GS-7340 HIV Protease
Tenofovir alafenamide
GS-7340(Tenofovir alafenamide) is a procompound of tenofovir (TFV) that more efficiently delivers TFV into lymphoid cells and tissues than TFV disoproxil fumarate.
M5051 Tenofovir Reverse Transcriptase
GS 1278; PMPA; TDF
Tenofovir is a nucleotide reverse transcriptase inhibitor used in studies related to HIV and chronic hepatitis B (HBV).
M5052 Tenofovir Disoproxil Fumarate HIV Protease
Tenofovir DF
Tenofovir Disoproxil Fumarate belongs to a class of antiretroviral compounds, it inhibits the activity of HIV reverse transcriptase by competing with the natural substrate deoxyadenosine 5’-triphosphate and, after incorporation into DNA, by DNA chain termination.
M6274 Tenofovir Disoproxil HIV Protease
Bis(POC)-PMPA; GS 4331
Tenofovir dsoproxil is a nucleotide reverse transcriptase inhibitor to treat HIV and chronic Hepatitis B.
M10364 Tenofovir hydrate HIV Protease
GS 1278 hydrate; PMPA hydrate
Tenofovir hydrate is a nucleotide reverse transcriptase inhibitor to treat HIV and chronic Hepatitis B.
M20783 Tenofovir alafenamide hemifumarate Reverse Transcriptase
TAF hemifumarate, GS-7340 hemifumarate
Tenofovir alafenamide (TAF, GS-7340) hemifumarate is a prodrug of tenofovir but results in significantly higher intracellular tenofovir concentrations and lower serum levels. Tenofovir alafenamide is a novel nucleotide reverse transcriptase inhibitor for the treatment of HIV-1 infection.
M20784 Tenofovir alafenamide fumarate Reverse Transcriptase
TAF fumarate, GS-7340 fumarate
Tenofovir alafenamide (TAF, GS-7340) fumarate is a precursor compound of Tenofovir and a novel nucleotide reverse transcriptase inhibitor for use in studies related to HIV-1 infection.
M30871 Tenofovir exalidex HIV Protease
CMX-157
Tenofovir exalidex (CMX157) is a lipid conjugate of the acyclic nucleotide analog Tenofovir with activity against both wild-type and antiretroviral drug-resistant HIV strains, including multidrug nucleoside/nucleotide analog-resistant viruses. Tenofovir exalidex is active against all major subtypes of HIV-1 and HIV-2 in fresh human PBMCs and against all HIV-1 strains evaluated in monocyte-derived macrophages, with EC50s ranging between 0.2 and 7.2 nM. CMX157 is orally available and has no apparent toxicity. Tenofovir exalidex also shows antiviral activity against HBV.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.